Nvidia and Eli Lilly Partner for $1 Billion AI Drug Lab in Silicon Valley
Business
M
Moneycontrol•12-01-2026, 20:52
Nvidia and Eli Lilly Partner for $1 Billion AI Drug Lab in Silicon Valley
- •Nvidia to invest $1 billion over five years in a new AI drug laboratory with Eli Lilly & Co. in Silicon Valley.
- •The partnership aims to accelerate the use of artificial intelligence in the pharmaceutical industry, streamlining drug discovery.
- •Nvidia, the world's most valuable corporation, seeks to expand its market beyond core tech customers into healthcare.
- •The joint lab will enable AI engineers to automate lab equipment and research tasks, reducing reliance on human researchers.
- •Nvidia is also expanding open-source AI models for healthcare, collaborating with Thermo Fisher Scientific and Multiply Labs for lab automation.
Why It Matters: Nvidia and Eli Lilly's $1 billion AI lab aims to revolutionize drug discovery by automating research processes.
✦
More like this
Loading more articles...
